Check out your Company Bowl for anonymous work chats.
Our CEO Jim Lang shares why we are thrilled to partner with Eyenovia Inc. to support, pending approval, the launch and commercialization of MydCombi, the first microdosed ocular therapeutic applied with a high precision smart delivery system. Learn more: http://ow.ly/gLPE50E6e9j
Our CEO Jim Lang shares why we are thrilled to partner with Eyenovia Inc. to support, pending approval, the launch and commercialization of MydCombi, the first microdosed ocular therapeutic applied with a high precision smart delivery system. Learn more: http://ow.ly/gLPE50E6e9j
At EVERSANA, we embrace diversity. Today we stand with the Asian community to denounce violence, hatred and intolerance. Together we must change the world. #StopAAPIHate #StopAsianHate
At EVERSANA, we embrace diversity. Today we stand with the Asian community to denounce violence, hatred and intolerance. Together we must change the world. #StopAAPIHate #StopAsianHate
Throughout Black History Month and beyond, EVERSANA employees are committed to awareness, education and living our cultural beliefs. Deidre Belton, a leader in our Patient Services team, recently shared her perspective on why this is a never-ending journey. #weareeversana #blackhistorymonth
Throughout Black History Month and beyond, EVERSANA employees are committed to awareness, education and living our cultural beliefs. Deidre Belton, a leader in our Patient Services team, recently shared her perspective on why this is a never-ending journey. #weareeversana #blackhistorymonth
We're excited to announce a collaboration with Iterum Therapeutics to support the launch of oral sulopenem for the treatment of uncomplicated urinary tract infections (uUTIs). Together we will immediately initiate pre-launch activities, followed by planned commercialization services! Learn more: http://ow.ly/q7SQ50Dnmle
We're excited to announce a collaboration with Iterum Therapeutics to support the launch of oral sulopenem for the treatment of uncomplicated urinary tract infections (uUTIs). Together we will immediately initiate pre-launch activities, followed by planned commercialization services! Learn more: http://ow.ly/q7SQ50Dnmle
Announcing an important partnership with Humanigen, Inc. in the fight against COVID-19. Together we’ll work to make lenzilumab available to hospitalized and hypoxic COVID-19 patients in the event that an Emergency Use Authorization is issued from the U.S. Food and Drug Administration (FDA) and subsequent BLA. Learn more http://ow.ly/mPjR50D4vgj
Announcing an important partnership with Humanigen, Inc. in the fight against COVID-19. Together we’ll work to make lenzilumab available to hospitalized and hypoxic COVID-19 patients in the event that an Emergency Use Authorization is issued from the U.S. Food and Drug Administration (FDA) and subsequent BLA. Learn more http://ow.ly/mPjR50D4vgj
As 2020 comes to a close, we’d like to express our sincere gratitude to our valued employees, clients, and partners worldwide. Together we navigated an unprecedented year and maintained an unconditional commitment to patients. You inspire us every day. Wishing all a healthier, peaceful 2021. Happy New Year!
As 2020 comes to a close, we’d like to express our sincere gratitude to our valued employees, clients, and partners worldwide. Together we navigated an unprecedented year and maintained an unconditional commitment to patients. You inspire us every day. Wishing all a healthier, peaceful 2021. Happy New Year!